Penumbra Cash on Hand 2014-2025 | PEN

Penumbra cash on hand from 2014 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Penumbra cash on hand for the quarter ending December 31, 2025 was $0.545B, a 60.18% increase year-over-year.
  • Penumbra cash on hand for 2025 was $0.545B, a 60.18% increase from 2024.
  • Penumbra cash on hand for 2024 was $0.34B, a 17.62% increase from 2023.
  • Penumbra cash on hand for 2023 was $0.289B, a 53.8% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Penumbra Annual Cash on Hand
(Millions of US $)
2025 $545
2024 $340
2023 $289
2022 $188
2021 $255
2020 $265
2019 $189
2018 $201
2017 $215
2016 $129
2015 $149
2014 $52
2013 $14
Penumbra Quarterly Cash on Hand
(Millions of US $)
2025-12-31 $545
2025-09-30 $470
2025-06-30 $425
2025-03-31 $379
2024-12-31 $340
2024-09-30 $291
2024-06-30 $340
2024-03-31 $313
2023-12-31 $289
2023-09-30 $249
2023-06-30 $221
2023-03-31 $199
2022-12-31 $188
2022-09-30 $184
2022-06-30 $204
2022-03-31 $240
2021-12-31 $255
2021-09-30 $267
2021-06-30 $239
2021-03-31 $243
2020-12-31 $265
2020-09-30 $269
2020-06-30 $278
2020-03-31 $168
2019-12-31 $189
2019-09-30 $194
2019-06-30 $187
2019-03-31 $195
2018-12-31 $201
2018-09-30 $194
2018-06-30 $207
2018-03-31 $215
2017-12-31 $215
2017-09-30 $219
2017-06-30 $220
2017-03-31 $233
2016-12-31 $129
2016-09-30 $142
2016-06-30 $140
2016-03-31 $144
2015-12-31 $149
2015-09-30 $159
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2013-12-31 $14
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $13.288B $1.195B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $189.665B 22.07
Intuitive Surgical (ISRG) United States $172.536B 66.55
IDEXX Laboratories (IDXX) United States $50.254B 48.15
Edwards Lifesciences (EW) United States $44.027B 29.64
Alcon (ALC) Switzerland $39.174B 26.40
IQVIA Holdings (IQV) United States $28.430B 15.36
Mettler-Toledo (MTD) United States $27.662B 31.81
DexCom (DXCM) United States $26.948B 33.50
STERIS (STE) Ireland $24.357B 24.64
Waters (WAT) United States $19.256B 24.63
Coloplast (CLPBY) Denmark $17.511B 26.79
Hologic (HOLX) United States $16.752B 17.53
SONOVA HOLDING (SONVY) Switzerland $15.334B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $14.168B 11.75
Globus Medical (GMED) United States $11.790B 24.74
SARTORIUS (SSSGY) Germany $7.976B 46.32
Masimo (MASI) United States $6.991B 22.40
Glaukos (GKOS) United States $6.287B 0.00
Sysmex ADR (SSMXY) Japan $5.363B 17.75
Teleflex (TFX) United States $4.585B 7.31
TransMedics (TMDX) United States $4.437B 52.57
LivaNova (LIVN) United Kingdom $3.593B 19.41
Integer Holdings (ITGR) United States $3.011B 14.13
Veracyte (VCYT) United States $2.828B 32.22
Elekta AB (EKTAY) Sweden $2.266B 21.19
Alphatec Holdings (ATEC) United States $1.985B 0.00
Nihon Kohden (NHNKY) Japan $1.975B 21.79
UFP Technologies (UFPT) United States $1.896B 25.03
Artivion (AORT) United States $1.734B 58.10
Pulse Biosciences (PLSE) United States $1.559B 0.00
PROCEPT BioRobotics (PRCT) United States $1.553B 0.00
AxoGen (AXGN) United States $1.533B 0.00
Tandem Diabetes Care (TNDM) United States $1.285B 0.00
IRadimed (IRMD) United States $1.270B 57.03
OPKO Health (OPK) United States $0.944B 0.00
Integra LifeSciences Holdings (IART) United States $0.882B 4.78
AVANOS MEDICAL, INC (AVNS) United States $0.692B 13.80
SiBone (SIBN) United States $0.665B 0.00
Beta Bionics (BBNX) United States $0.614B 0.00
Alpha Tau Medical (DRTS) Israel $0.612B 0.00
Tactile Systems Technology (TCMD) United States $0.591B 34.35
ORTHOFIX MEDICAL INC (OFIX) United States $0.530B 0.00
Pacific Biosciences Of California (PACB) United States $0.516B 0.00
NeuroPace (NPCE) United States $0.501B 0.00
Mesa Laboratories (MLAB) United States $0.500B 13.03
AngioDynamics (ANGO) United States $0.452B 0.00
OrthoPediatrics (KIDS) United States $0.424B 0.00
ClearPoint Neuro (CLPT) United States $0.385B 0.00
RxSight (RXST) United States $0.331B 0.00
Delcath Systems (DCTH) United States $0.329B 54.76
Semler Scientific (SMLR) United States $0.311B 2.32
Sight Sciences (SGHT) United States $0.283B 0.00
Spectral Diagnostics (EDTXF) Canada $0.281B 0.00
Anteris Technologies Global (AVR) Australia $0.235B 0.00
908 Devices (MASS) United States $0.235B 0.00
Lucid Diagnostics (LUCD) United States $0.183B 0.00
EDAP TMS S.A (EDAP) France $0.175B 0.00
Rapid Micro Biosystems (RPID) United States $0.173B 0.00
Inogen (INGN) United States $0.156B 0.00
Nano-X Imaging (NNOX) Israel $0.149B 0.00
LENSAR (LNSR) United States $0.146B 0.00
Microbot Medical (MBOT) United States $0.146B 0.00
Zomedica (ZOMDF) United States $0.132B 0.00
CVRx (CVRX) United States $0.130B 0.00
Treace Medical Concepts (TMCI) United States $0.119B 0.00
Hyperfine (HYPR) United States $0.108B 0.00
Neuronetics (STIM) United States $0.097B 0.00
Solana (HSDT) United States $0.091B 0.00
DarioHealth (DRIO) United States $0.079B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
InspireMD (NSPR) United States $0.074B 0.00
Positron (POSC) United States $0.067B 0.00
QT Imaging Holdings (QTI) United States $0.067B 0.00
Sensus Healthcare (SRTS) United States $0.063B 0.00
Accuray (ARAY) United States $0.062B 0.00
Spectral AI (MDAI) United States $0.048B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Atossa Genetics (ATOS) United States $0.036B 0.00
Ekso Bionics Holdings (EKSO) United States $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.021B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Envoy Medical (COCH) United States $0.017B 0.00
Check-Cap (MBAI) Israel $0.013B 0.00
Vicarious Surgical (RBOT) United States $0.012B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
NexGel (NXGL) United States $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
EnVVeno Medical (NVNO) United States $0.006B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00